Search company, investor...

Predict your next investment

Corporation
HEALTHCARE | Drug Development
4dpharmaplc.com

Partners & Customers

8

About 4D Pharma

4D Pharma (NASDAQ: LBPS) researches and develops pharmaceutical products in new live biotherapeutic areas in the United Kingdom. The Company's first-generation programs include Blautix, a treatment for irritable bowel syndrome; Thetanix, a treatment for pediatric Crohns; and Rosburix, a treatment for pediatric ulcerative colitis.

Headquarters Location

9 Bond Court Third Floor

Leeds, England, LS1 2JZ,

United Kingdom

+44 (0) 113 895 0130

Want to inform investors similar to 4D Pharma about your company?

Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.

Latest 4D Pharma News

Q3 results this week: L&T, Bajaj Finserv, Sun Pharma, Tech Mahindra, Ashok Leyland and others

Jan 29, 2023

Results that will be out on January 30 include Larsen & Toubro, Bajaj Finserv, Tech Mahindra, Bharat Petroleum Corporation, Bajaj Holdings & Investment, GAIL, SRF, Punjab National Bank, REC, Laurus Labs, IIFL Finance, Trident, Exide Industries, Nippon Life India Asset Management, Mazagon Dock Shipbuilders, Welspun as well as Inox Leisure.

4D Pharma Acquisitions

2 Acquisitions

4D Pharma acquired 2 companies. Their latest acquisition was Biomar on April 08, 2016.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

4/8/2016

$99M

Acquired

3

2/15/2016

Subscribe to see more

$99M

Subscribe to see more

10

Date

4/8/2016

2/15/2016

Investment Stage

Companies

Subscribe to see more

Valuation

$99M

$99M

Total Funding

Note

Acquired

Subscribe to see more

Sources

3

10

4D Pharma Partners & Customers

8 Partners and customers

4D Pharma has 8 strategic partners and customers. 4D Pharma recently partnered with Columbia Care on October 10, 2021.

Date

Type

Business Partner

Country

News Snippet

Sources

10/21/2021

Partner

United States

Cannabis capsules on prescription: Simplifying medical cannabis for patients and doctors - Grow

The capsules are manufactured under the highest standards , by Columbia Care 's UK partner , IPS Pharma -- a leading pharmaceutical manufacturer that is licensed by the UK 's Medicines and Healthcare products Regulatory Agency and distributed by Columbia Care 's UK market access partner , Grow Pharma Ltd. .

1

8/25/2021

Partner

United States

Subscribe to see more

Subscribe to see more

10

7/27/2021

Vendor

Spain

Subscribe to see more

Subscribe to see more

10

6/15/2021

Partner

Germany

Subscribe to see more

Subscribe to see more

10

10/10/2019

Partner

United States

Subscribe to see more

Subscribe to see more

10

Date

10/21/2021

8/25/2021

7/27/2021

6/15/2021

10/10/2019

Type

Partner

Partner

Vendor

Partner

Partner

Business Partner

Country

United States

United States

Spain

Germany

United States

News Snippet

Cannabis capsules on prescription: Simplifying medical cannabis for patients and doctors - Grow

The capsules are manufactured under the highest standards , by Columbia Care 's UK partner , IPS Pharma -- a leading pharmaceutical manufacturer that is licensed by the UK 's Medicines and Healthcare products Regulatory Agency and distributed by Columbia Care 's UK market access partner , Grow Pharma Ltd. .

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

1

10

10

10

10

4D Pharma Team

1 Team Member

4D Pharma has 1 team member, including former Chief Medical Officer, John Weinberg.

Name

Work History

Title

Status

John Weinberg

Chief Medical Officer

Former

Name

John Weinberg

Work History

Title

Chief Medical Officer

Status

Former

Compare 4D Pharma to Competitors

SciBac Logo
SciBac

SciBac aims to target Clostridium difficile (C. diff), a potentially fatal and often recurring gastrointestinal infection. Using "Evolutionary" live biotherapeutics, it stops colonization, neutralizes toxins, and directly kills C. diff organisms. The company is also developing a single-strain inhaled biotherapeutic for patients with cystic fibrosis. That therapy aims to break down the problematic mucus in the patient's lungs, while also suppressing dangerous Pseudomonas aeruginosa bacteria.

Vedanta Biosciences Logo
Vedanta Biosciences

Vedanta Biosciences is a clinical-stage company developing a new category of therapies for immune-mediated diseases based on rationally-defined consortia of human microbiome-derived bacteria.

A
Alveolus

Alveolus develops therapeutics for lung diseases such as live biotherapeutics for Bronchopulmonary Dysplasia (BPD), Chronic Obstructive Pulmonary Disease (COPD), Idiopathic Pulmonary Fibrosis (IPF), and Pulmonary Arterial Hypertension (PAH).

Seres Therapeutics Logo
Seres Therapeutics

Seres Therapeutics is a clinical-stage therapeutics company developing products to treat a host of disease conditions based on scientific findings related to the human microbiome. The company is developing candidates for the treatment of infectious, metabolic, and inflammatory diseases.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.